“Real World” Thoracic Endografting: Results With the Gore TAG Device 2 Years After U.S. FDA Approval

Hughes, G. Chad; Daneshmand, Mani A.; Swaminathan, Madhav; Nienaber, Jeffrey J.; Bush, Errol L.; Husain, Aatif; Wolfe, Walter G.; McCann, Richard L.

doi:10.1016/j.athoracsur.2008.07.089

Cited by 62 publications

(61 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this particular patient, as well as in others with aortic arch and visceral segment aortic involvement, endovascular strategies would require use of branched endografts 15 or a hybrid approach with concomitant debranching. 16 Concerns exist, however, about the use of endovascular techniques to treat aortic disease in patients with Marfan syndrome and other connective tissue disorders 17 due to increased early failure rates in this population and because these patients are generally young and do well with open repair, as with the patient reported.…”

Section: Discussionmentioning

confidence: 90%

Two-Stage Total Cardioaortic Replacement for End-Stage Heart and Aortic Disease in Marfan Syndrome: Case Report and Review of the Literature

Rajagopal

Rogers

Lodge

et al. 2009

The Journal of Heart and Lung Transplantation

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 90%

Two-Stage Total Cardioaortic Replacement for End-Stage Heart and Aortic Disease in Marfan Syndrome: Case Report and Review of the Literature

Rajagopal

Rogers

Lodge

et al. 2009

The Journal of Heart and Lung Transplantation

Self Cite

View full text Add to dashboard Cite

“…Such long-term stability in patients with stented aorta may be dissection specific and explained by healing, and thereby different from less encouraging experience in aneurysmatic disease. 28 Although elective crossover and endovascular reintervention were generally safe, corroborating observations in chronic type B dissection, 14 emergency TEVAR portends considerable mortality 29,30 ; emergencies may in fact be avoided by both imaging surveillance and elective TEVAR.…”

Section: Downloaded Frommentioning

confidence: 91%

Endovascular Repair of Type B Aortic Dissection

Nienaber

Kische

Rousseau

et al. 2013

Circ: Cardiovascular Interventions

920

View full text Add to dashboard Cite

Background-Thoracic endovascular aortic repair (TEVAR) represents a therapeutic concept for type B aortic dissection.Long-term outcomes and morphology after TEVAR for uncomplicated dissection are unknown. Methods and Results-A total of 140 patients with stable type B aortic dissection previously randomized to optimal medical treatment and TEVAR (n=72) versus optimal medical treatment alone (n=68) were analyzed retrospectively for aortaspecific, all-cause outcomes, and disease progression using landmark statistical analysis of years 2 to 5 after index procedure. Cox regression was used to compare outcomes between groups; all analyses are based on intention to treat. From the University of Rostock, Heart Center and Institute for Biostatistics, Rostock, Germany (C.A.N., S.K., T.C.R., G.K., A.G., T.K., H.I.); CCB Heart Center Frankfurt, Frankfurt, Germany (H.E.); University Heart Center Leipzig, Leipzig, Germany (D.S.); German Heart Institute Berlin, Berlin, Germany (B.Z.); the Centre Hospitalière Universitaire, Hôpital de Rangueil, Toulouse, France (H.R.); the Universitá St. Orsola Malpighi, Bologna, Italy (R.F.); the Department of Cardiovascular Surgery, University Hospital Berne, Berne, Switzerland (M.C.); and Bordeaux Heart University Hospital, Bordeaux, France (L.L.).All members of the Investigation of Stent grafts in Aortic Dissection with extended length of follow-up (INSTEAD-XL) study group are listed in the Appendix in the online-only Data Supplement.The online-only Data Supplement is available at http://circinterventions.ahajournals.org/lookup/suppl

show abstract

“…4 The popularity of endovascular stent grafting has been increasing exponentially, since several studies showed feasibility and lower morbidity and mortality rates of endovascular treatment compared to open repair. 5,6 Extensive thoracic and thoracoabdominal aortic aneurysms, particularly those involving the arch or viscero-renal vessels, are associated with substantial surgery-related morbidities, yet are often anatomically unsuitable for endovascular repair due to inadequate landing zone(s). 7,8 A balance needs to be drawn between the morbidity of open surgery and the physiological reserves of the patient.…”

mentioning

confidence: 99%